NCBiotech News

Raleigh-based Marius Pharmaceuticals has received federal approval for its first drug.

The North Carolina Biotechnology Center awarded 32 grants and loans totaling $3,304,543 to universities, bioscience companies and nonprofit organizations in the fourth quarter of its fiscal year.

Burlington-based Labcorp plans to spin off its wholly owned Clinical Development business as an independent, publicly traded company.

Indian pharmaceutical maker Ipca Laboratories Limited, parent company of Pisgah Labs in Western North Carolina, says it will spend $55 million to expand its manufacturing product line at the Transylvania County facility.

Dechra Pharmaceuticals of England is paying $210 million in cash to buy Greensboro-based Piedmont Animal Health, a successful NC startup bootstrapped with NCBiotech loan funding.

A research award program that Altis Biosystems introduced last year to encourage the use of its drug-development technology worked so well the company is at it again this year.

Business Facilities, a publication for corporate site selectors and economic developers, has designated North Carolina as having the best business climate in the nation, days after CNBC also named NC the country’s top state for business in 2022,

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

North Carolina has been named by CNBC as “America’s Top State for Business in 2022.”

Burlington-based Labcorp has begun selling the first widely accessible test for direct evidence of neurodegeneration and neuronal injury.

MAKO, a national reference laboratory based in Raleigh, has validated a PCR-based monkeypox-specific research assay developed by Thermo Fisher Scientific.

Burlington-based Labcorp will begin offering a diagnostic test for the monkeypox virus, and Bavarian Nordic, a Danish company with a U.S. subsidiary in Morrisville, will provide the only monkeypox vaccine approved by the FDA.

Durham-based Deep Blue Medical Advances has raised more than $7 million in venture capital to commercialize a device for repairing hernias.

North Carolina’s Research Triangle region is the nation’s fourth leading hub for biotechnology activity, trailing only Boston, San Francisco and San Diego, says Fierce Biotech, an online publication that covers the biotechnology and pharmaceutical industries.

Cary-based Atom Bioworks (Atombio) has been selected as one of 14 promising global life-sciences startups to participate in the BioTools Innovator Accelerator program.